Furthermore, treatment with siRNA of CDK5 or inhibitors reduced Digoxin-triggered prostate cancer cell death, suggesting that CDK5 plays an essential role in Digoxin-triggered prostate cancer cell death. This evidence concerns the gene CDK5 and Familial prostate cancer.